A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer
| Autor: | Monk, Bradley J., Herzog, Thomas J., Wang, George, Triantos, Spyros, Maul, Scott, Knoblauch, Roland, McGowan, Tracy, Shalaby, Waleed S.W., Coleman, Robert L. |
|---|---|
| Zdroj: | In Gynecologic Oncology March 2020 156(3):535-544 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect